Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy

SIMPLE SUMMARY: An important clinical issue to consider when selecting neoadjuvant chemotherapy treatment for breast cancer is the likelihood of cancer recurrence. Accurately predicting the future outcome of the patient based on data available prior to treatment initiation could impact the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabinovici-Cohen, Simona, Fernández, Xosé M., Grandal Rejo, Beatriz, Hexter, Efrat, Hijano Cubelos, Oliver, Pajula, Juha, Pölönen, Harri, Reyal, Fabien, Rosen-Zvi, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405765/
https://www.ncbi.nlm.nih.gov/pubmed/36010844
http://dx.doi.org/10.3390/cancers14163848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405765/
https://www.ncbi.nlm.nih.gov/pubmed/36010844
http://dx.doi.org/10.3390/cancers14163848

Ejemplares similares